16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
Imagine the courage it must take to blow the whistle on unethical activity at your job. Whistleblowe...
Read More >
Joining the other federal appellate panels to consider the issue, the U.S. Court of Appeals for the ...
Read More >
On September 18, 2019, Governor Newsom signed Assembly Bill 5, thereby establishing a law that purpo...
Read More >
Primary HSR filing threshold will be decreased to $92 million - The Federal Trade Commission has a...
Read More >
The Federal Trade Commission (FTC) has revised the thresholds that govern pre-merger notification re...
Read More >
Last week, John Bulman and I attended the National Construction Dispute Resolution Committee’s (NCD...
Read More >